APOBEC3G Contributes to HIV-1 Variation through Sublethal Mutagenesis

被引:139
|
作者
Sadler, Holly A. [1 ,2 ]
Stenglein, Mark D. [1 ,3 ,5 ]
Harris, Reuben S. [1 ,3 ,5 ]
Mansky, Louis M. [1 ,2 ,4 ]
机构
[1] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Diagnost & Biol Sci, Sch Dent, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Sch Med, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Microbiol, Sch Med, Minneapolis, MN 55455 USA
[5] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION; CYTIDINE DEAMINASES; MUTATIONAL ANALYSIS; DRUG-RESISTANCE; ENZYME APOBEC3G; POOL IMBALANCES; VIF PROTEIN; VIRAL-RNA; IN-VIVO;
D O I
10.1128/JVI.00056-10
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mammalian APOBEC3 proteins are an important component of the cellular innate immune response to retroviral infection. APOBEC3G can extinguish HIV-1 infectivity by its incorporation into virus particles and subsequent cytosine deaminase activity that attacks the nascent viral cDNA during reverse transcription, causing lethal mutagenesis. It has been suggested, but not formally shown, that APOBEC3G can also induce sublethal mutagenesis, which would maintain virus infectivity and contribute to HIV-1 variation. To test this, we developed a novel model system utilizing an HIV-1 vector and a panel of APOBEC3G-expressing cells. We observed proviruses with single APOBEC3G-mediated mutations (in the presence or absence of Vif), occurring at distinct hot spots and which could be rescued and shown to have infectivity. These data indicate that APOBEC3G-dependent restriction of HIV-1 can result in viable viral progeny that harbor sublethal levels of G-to-A mutations. Such mutations have the potential to contribute significantly to HIV-1 evolution, pathogenesis, immune escape, and drug resistance.
引用
收藏
页码:7396 / 7404
页数:9
相关论文
共 50 条
  • [31] RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1
    Huthoff, Hendrik
    Autore, Flavia
    Gallois-Montbrun, Sarah
    Fraternali, Franca
    Malim, Michael H.
    PLOS PATHOGENS, 2009, 5 (03)
  • [32] APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso
    Compaore, Tegwinde Rebeca
    Soubeiga, Serge Theophile
    Ouattara, Abdoul Karim
    Obiri-Yeboah, Dorcas
    Tchelougou, Damehan
    Maiga, Mamoudou
    Assih, Maleki
    Bisseye, Cyrille
    Bakouan, Didier
    Compaore, Issaka Pierre
    Dembele, Augustine
    Martinson, Jeremy
    Simpore, Jacques
    PLOS ONE, 2016, 11 (01):
  • [33] APOBEC3g mediates innate resistance of Dendritic Cells to HIV-1 infection
    Pion, M.
    Stalder, R.
    Piguet, V
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 108 - 108
  • [34] Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides
    Richards, Christopher M.
    Li, Ming
    Perkins, Angela L.
    Rathore, Anurag
    Harki, Daniel A.
    Harris, Reuben S.
    JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (01) : 88 - 96
  • [35] Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction
    He, Zhiwen
    Zhang, Wenyan
    Chen, Gongying
    Xu, Rongzhen
    Yu, Xiao-Fang
    JOURNAL OF MOLECULAR BIOLOGY, 2008, 381 (04) : 1000 - 1011
  • [36] APOBEC3G Impairs the Multimerization of the HIV-1 Vif Protein in Living Cells
    Batisse, Julien
    Guerrero, Santiago Xavier
    Bernacchi, Serena
    Richert, Ludovic
    Godet, Julien
    Goldschmidt, Valerie
    Mely, Yves
    Marquet, Roland
    de Rocquigny, Hugues
    Paillart, Jean-Christophe
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6492 - 6506
  • [37] Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G
    Chen, Kuan-Ming
    Harjes, Elena
    Gross, Phillip J.
    Fahmy, Amr
    Lu, Yongjian
    Shindo, Keisuke
    Harris, Reuben S.
    Matsuo, Hiroshi
    NATURE, 2008, 452 (7183) : 116 - U16
  • [38] Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G
    Iwatani, Yasumasa
    Chan, Denise S. B.
    Wang, F.
    Maynard, Kristen Stewart
    Sugiura, Wataru
    Gronenborn, Angela M.
    Rouzina, Ioulia
    Williams, Mark C.
    Musier-Forsyth, Karin
    Levin, Judith G.
    NUCLEIC ACIDS RESEARCH, 2007, 35 (21) : 7096 - 7108
  • [39] The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
    Ann M Sheehy
    Nathan C Gaddis
    Michael H Malim
    Nature Medicine, 2003, 9 : 1404 - 1407
  • [40] HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation
    Mercenne, Gaelle
    Bernacchi, Serena
    Richer, Delphine
    Bec, Guillaume
    Henriet, Simon
    Paillart, Jean-Christophe
    Marquet, Roland
    NUCLEIC ACIDS RESEARCH, 2010, 38 (02) : 633 - 646